author-photo

James M. Carroll

University of California, Los Angeles

18

Papers

841

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Detection of EGFR Mutations in cfDNA and CTCs, and Comparison to Tumor Tissue in Non-Small-Cell-Lung-Cancer (NSCLC) Patients

2020 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Tumor characteristics associated with benefit from pembrolizumab in advanced non-small cell lung cancer

2019 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (31)
Electrostatic human leukocyte antigen-neoantigen interactions and durable benefit in non-small cell lung cancer patients treated with immunotherapy.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1598: EGFR mutational detection in vortex-enriched CTCs, ctDNA, and comparison to tumor tissue in non-small cell lung cancer (NSCLC) patients

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

2018 Science
Show All
- Source
- Cite
- Save
Citations (467)
A phase II study of pembrolizumab in EGFR-mutant, PD-L1+, tyrosine kinase inhibitor (TKI) naïve patients with advanced NSCLC.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Low Concordance of Patient-Reported Outcomes With Clinical and Clinical Trial Documentation

2018
Show All
- Source
- Cite
- Save
Citations (7)
Clinical Implications of the T790M Mutation in Disease Characteristics and Treatment Response in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Non–Small-Cell Lung Cancer (NSCLC)

2018 Clinical Lung Cancer
Show All
- Source
- Cite
- Save
Citations (9)
Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center

2018 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (49)
Clinical implications of the T790M mutation in disease characteristics and treatment response in patients with EGFR-mutated NSCLC.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)